Law firm · United States

WilmerHale

Deals
7
M&A
6
IPOs
1
Latest
Sep 2026
Compare

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deal size
Custom range

7 of 7 deals

Deals WilmerHale advised on, most recent first
Advisers
Sep 2026 Vestmark –EnvestnetAcquisitionLegal adviser to Vestmark (target)Announced–Wealthtech+2 Ropes & Gray (buy-side)UBS (buy-side)Goldman Sachs (buy-side)RBC Capital Markets (buy-side)J.P. Morgan (buy-side)Morgan Stanley (buy-side)Raymond James (sell-side)Berenson & Company (sell-side) Envestnet acquisition of Vestmark
Jul 2026 Giant Eagle –The Kroger Co.AcquisitionLegal adviser to Giant Eagle (target)Announced1,250.0Food Retail+1 RBC Capital Markets (buy-side)Jones Day (buy-side)Wells Fargo Securities (sell-side)Troutman Pepper Locke (sell-side) The Kroger Co. acquisition of Giant Eagle
Apr 2026 Hemab Therapeutics Holdings ––IPOLegal adviser to the issuerAnnounced301.5Biotech+1 Goldman Sachs (lead manager)Jefferies (lead manager)Evercore (lead manager)Wedbush Securities (lead manager)Goodwin (lead manager) Hemab Therapeutics Holdings IPO
Mar 2026 Apellis Pharmaceuticals –BiogenAcquisitionLegal adviser to Apellis Pharmaceuticals (target)Announced5,600.0Biotech+2 Lazard (buy-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)Cravath, Swaine & Moore (buy-side) Biogen acquisition of Apellis Pharmaceuticals
Mar 2026 UpSwell Marketing –Mountaingate CapitalAcquisitionLegal adviser to Mountaingate Capital (acquirer)Completed–Advertising and marketing BrightTower (sell-side) Mountaingate Capital acquisition of UpSwell Marketing
Jan 2026 Mersana Therapeutics –Day One BiopharmaceuticalsAcquisitionLegal adviser to Mersana (target)Completed–Biotech+2 Gordon Dyal & Co. (buy-side)Fenwick & West (buy-side)TD Securities (sell-side) Day One Biopharmaceuticals acquisition of Mersana Therapeutics
Dec 2025 Generation Bio Co. –XRA 7 Corp.AcquisitionLegal adviser to Generation Bio Co. (target)Announced–Biotech+1 TD Securities (sell-side)Gibson Dunn (buy-side) XRA 7 Corp. acquisition of Generation Bio Co.

Activity

Deals by year
WilmerHale: deals by year2025: 1, 2026 YTD: 60362025: 1 M&A120252026 YTD: 5 M&A2026 YTD: 1 Equity raisings62026 YTDM&AEquity raisings

By announcement date; raisings and IPOs by their own date.

Deals by sector
WilmerHale: deals by sectorBiotech4Advertising and marketing1Food Retail1Wealthtech1

Sector of the business bought or funded.

Deals by size
WilmerHale: deals by sizeUS$100–500m1US$1bn+2Undisclosed4

Disclosed value in US dollars.

Most often across the table

Firms advising the other side of the same deals.

Offices and contact

Contact

From the firm's own website.

Suggest a correction

A missing deal, a wrong role or an office to add. A link to a public source helps.